Persistence of lymphocyte function perturbations after granulocyte-colony- stimulating factor mobilization and cytapheresis in normal peripheral blood stem cell donors

Transfusion

Volumn 50, Issue 12, 2010, Pages 2676-2685

  Marmier Savet, Caroline ^a   Larosa, Fabrice ^a   Legrand, Faezeh ^a   Witz, Brigitte ^a   Michallet, Mauricette ^a   Ranta, Dana ^a   Louvat, Pascale ^a   Puyraveau, Marc ^a   Pouthier, Fabienne ^a   Deconinck, Eric ^a   Tiberghien, Pierre ^a   Robinet, Eric ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 8; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CLINICAL TRIAL; CYTAPHERESIS; CYTOKINE RELEASE; DENDRITIC CELL; DONOR; EOSINOPHIL COUNT; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOGLOBULIN PRODUCTION; IMMUNOPATHOLOGY; IN VITRO STUDY; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MALE; MONOCYTE; NATURAL KILLER CELL; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL BLOOD STEM CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; STEM CELL MOBILIZATION; THROMBOCYTE COUNT;

EID: 78650011517     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02781.x     Document Type: Article

References (37)

1. Korbling M, Huh YO, Durett A, Mirza N, Miller P, Engel H, Anderlini P, Van Besien K, Andreeff M, Przepiorka D, Deisseroth AB, Champlin RE,. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy- 1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 1995; 86: 2842-8.
2. Dreger P, Haferlach T, Eckstein V, Jacobs S, Suttorp M, Löffler H, Müller-Ruchholtz W, Schmitz N,. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol 1994; 87: 609-13.
3. Rutella S, Danese S, Leone G,. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 2006; 108: 1435-40.
4. Mielcarek M, Martin PJ, Torok-Storb B,. Suppression of alloantigen-induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood 1997; 89: 1629-34.
5. Mielcarek M, Graf L, Johnson G, Torok-Storb B,. Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: a mechanism for monocyte-mediated suppression of T-cell proliferation. Blood 1998; 92: 215-22.
6. Rondelli D, Raspadori D, Anasetti C, Bandini G, Re F, Arpinati M, Stanzani M, Morelli A, Baccini C, Zaccaria A, Lemoli RM, Tura S,. Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells. Bone Marrow Transplant 1998; 22: 631-7.
7. Singh RK, Ino K, Varney ML, Heimann DG, Talmadge JE,. Immunoregulatory cytokines in bone marrow and peripheral blood stem cell products. Bone Marrow Transplant 1999; 23: 53-62.
8. Hartung T, Doecke WD, Bundschuh D, Foote MA, Gantner F, Hermann C, Lenz A, Milwee S, Rich B, Simon B, Volk HD, Von Aulock S, Wendel A,. Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functions. Clin Pharmacol Ther 1999; 66: 415-24.
9. Nawa Y, Teshima T, Sunami K, Hiramatsu Y, Maeda Y, Yano T, Shinagawa K, Ishimaru F, Omoto E, Harada M,. G-CSF reduces IFN-gamma and IL-4 production by T cells after allogeneic stimulation by indirectly modulating monocyte function. Bone Marrow Transplant 2000; 25: 1035-40.
10. Miller JS, Prosper F, McCullar V,. Natural killer (NK) cells are functionally abnormal and NK cell progenitors are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections. Blood 1997; 90: 3098-105.
11. Ageitos AG, Singh RK, Ino K, Ozerol I, Tarantolo S, Reed EK, Talmadge JE,. IL-2 expansion of T and NK cells from growth factor-mobilized peripheral blood stem cell products: monocyte inhibition. J Immunother (1997) 1998; 21: 409-17.
12. Tayebi H, Kuttler F, Saas P, Lienard A, Petracca B, Lapierre V, Ferrand C, Fest T, Cahn J, Blaise D, Kuentz M, Hervé P, Tiberghien P, Robinet E,. Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells. Exp Hematol 2001; 29: 458-70.
13. Sloand EM, Kim S, Maciejewski JP, Van Rhee F, Chaudhuri A, Barrett J, Young NS,. Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood 2000; 95: 2269-74.
14. Hartung T, Docke WD, Gantner F, Gantner F, Krieger G, Sauer A, Stevens P, Volk HD, Wendel A,. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 1995; 85: 2482-9.
15. Rutella S, Pierelli L, Bonanno G, Sica S, Ameglio F, Capoluongo E, Mariotti A, Scambia G, D'Onofrio G, Leone G,. Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells. Blood 2002; 100: 2562-71.
16. Arpinati M, Green CL, Heimfeld S, Heuser JE, Anasetti C,. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 2000; 95: 2484-90.
17. Tayebi H, Lapierre V, Saas P, Lienard A, Sutton L, Milpied N, Attal M, Cahn JY, Kuentz M, Blaise D, Hervé P, Tiberghien P, Robinet E,; Société Française de Greffe de Moelle et de Therapie Cellulaire. Enhanced activation of B cells in a granulocyte colony-stimulating factor-mobilized peripheral blood stem cell graft. Br J Haematol 2001; 114: 698-700.
18. Morikawa K, Miyawaki T, Oseko F, Morikawa S, Imai K,. G-CSF enhances the immunoglobulin generation rather than the proliferation of human B lymphocytes. Eur J Haematol 1993; 51: 144-51.
19. Lapierre V, Auperin A, Tayebi H, Chabod J, Saas P, Michalet M, François S, Garban F, Giraud C, Tramalloni D, Oubouzar N, Blaise D, Kuentz M, Robinet E, Tiberghien P,; Société Française de Greffe de Moelle et de Thérapiue Cellulaire. Increased presence of anti-HLA antibodies early after allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood hematopoietic stem cell transplantation compared with bone marrow transplantation. Blood 2002; 100: 1484-9.
20. Lapierre V, Oubouzar N, Auperin A, Tramalloni D, Tayebi H, Robinet E, Kuentz M, Blaise D, Hartmann O, Hervé P, Tiberghien P,; Société Française de Greffe de Moelle. Influence of the hematopoietic stem cell source on early immunohematologic reconstitution after allogeneic transplantation. Blood 2001; 97: 2580-6.
21. Nagler A, Korenstein-Ilan A, Amiel A, Avivi L,. Granulocyte colony-stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells. Exp Hematol 2004; 32: 122-30.
22. Kaplinsky C, Trakhtenbrot L, Hardan I, Reichart M, Daniely M, Toren A, Amariglio N, Rechavi G, Izraeli S,. Tetraploid myeloid cells in donors of peripheral blood stem cells treated with rhG-CSF. Bone Marrow Transplant 2003; 32: 31-4.
23. Tigue CC, McKoy JM, Evens AM, Trifilio SM, Tallman MS, Bennettl CL,. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone Marrow Transplant 2007; 40: 185-92.
24. Marmier-Savet C, Larosa F, Legrand F, Witz B, Michallet M, Ranta D, Louvat P, Puyraveau M, Raus N, Tavernier M, Mathieu-Nafissi S, Hequet O, Pallandre JR, Vitte F, Collonge-Rame MA, Pouthier F, Bresson JL, Deconinck E, Tiberghien P, Robinet E,. G-CSF-induced aneuploîdy does not affect CD34+ cells and does not require cell division. Blood 2010; 115: 910-1.
25. Tassi C, Tazzari PL, Bonifazi F, Giudice V, Nannetti A, Ricci F, Rizzi S, Bandini G, Conte R,. Short- and long-term haematological surveillance of healthy donors of allogeneic peripheral haematopoietic progenitors mobilized with G-CSF: a single institution prospective study. Bone Marrow Transplant 2005; 36: 289-94.
26. Martinez C, Urbano-Ispizua A, Mazzara R, Rozman C, Montserrat E,. Granulocyte colony-stimulating factor administration and peripheral blood progenitor cells collection in normal donors: analysis of leukapheresis-related side effects. Blood 1996; 87: 4916-7.
27. Martinez C, Urbano-Ispizua A, Rozman C, Marín P, Mazzara R, Carreras E, Rovira M, Sierra J, Briones J, Ordinas A, Montserrat E,. Effects of G-CSF administration and peripheral blood progenitor cell collection in 20 healthy donors. Ann Hematol 1996; 72: 269-72.
28. Anderlini P, Przepiorka D, Seong D, Champlin R, Körbling M,. Transient neutropenia in normal donors after G-CSF mobilization and stem cell apheresis. Br J Haematol 1996; 94: 155-8. (Pubitemid 26232558)
29. Korbling M, Anderlini P, Durett A, Maadani F, Bojko P, Seong D, Giralt S, Khouri I, Andersson B, Mehra R, Van Besien K, Mirza N, Przepiorka D, Champlin R,. Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation. Bone Marrow Transplant 1996; 18: 1073-9.
30. Rahmoun M, Foussat A, Groux H, Pène J, Yssel H, Chanez P,. Enhanced frequency of CD18- and CD49b-expressing T cells in peripheral blood of asthmatic patients correlates with disease severity. Int Arch Allergy Immunol 2006; 140: 139-49.
31. Klangsinsirikul P, Russell NH,. Peripheral blood stem cell harvests from G-CSF-stimulated donors contain a skewed Th2 CD4 phenotype and a predominance of type 2 dendritic cells. Exp Hematol 2002; 30: 495-501.
32. Papayannopoulou T,. Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization. Blood 2004; 103: 1580-5.
33. Stroncek DF, Clay ME, Herr G, Smith J, Ilstrup S, McCullough J,. Blood counts in healthy donors 1 year after the collection of granulocyte-colony- stimulating factor-mobilized progenitor cells and the results of a second mobilization and collection. Transfusion 1997; 37: 304-8.
34. Storek J, Dawson MA, Maloney DG,. Normal T, B, and NK cell counts in healthy donors at 1 year after blood stem cell harvesting. Blood 2000; 95: 2993-4.
35. Cavallaro AM, Lilleby K, Majolino I, Storb R, Appelbaum FR, Rowley SD, Bensinger WI,. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor. Bone Marrow Transplant 2000; 25: 85-9.
36. Fraser AR, Cook G, Franklin IM, Templeton JG, Campbell M, Holyoake TL, Campbell JD,. Immature monocytes from G-CSF-mobilized peripheral blood stem cell collections carry surface-bound IL-10 and have the potential to modulate alloreactivity. J Leukoc Biol 2006; 80: 862-9.
37. Mehrad B, Strieter RM, Moore TA, Tsai WC, Lira SA, Standiford TJ,. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis. J Immunol 1999; 163: 6086-94.